Literature DB >> 20428843

Guillain-Barré syndrome related to pandemic influenza A (H1N1) infection.

Anis Chaari, Mabrouk Bahloul, Hassen Dammak, Gharbi Nourhene, Noureddine Rekik, Chelly Hedi, Ben Hamida Chokri, Mounir Bouaziz.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20428843     DOI： 10.1007/s00134-010-1895-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barré syndrome.

Authors:  David Orlikowski; Tarek Sharshar; Raphael Porcher; Djillali Annane; Jean Claude Raphael; Bernard Clair
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

Review 2.  Guillain-Barré syndrome.

Authors:  Richard A C Hughes; David R Cornblath
Journal:  Lancet       Date:  2005-11-05       Impact factor: 79.321

Review 3.  Guillain-Barré syndrome.

Authors:  V Cosi; M Versino
Journal:  Neurol Sci       Date:  2006-03       Impact factor: 3.307

4.  Guillain-Barré syndrome and influenza virus infection.

Authors:  Valérie Sivadon-Tardy; David Orlikowski; Raphaël Porcher; Tarek Sharshar; Marie-Christine Durand; Vincent Enouf; Flore Rozenberg; Christiane Caudie; Djillali Annane; Sylvie van der Werf; Pierre Lebon; Jean-Claude Raphaël; Jean-Louis Gaillard; Elyanne Gault
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079
  4 in total
  6 in total

Review 1.  Infection and autoimmune disease.

Authors:  Asli Gamze Sener; Ilhan Afsar
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

Review 2.  [Guillain-Barré syndrome after exposure to influenza].

Authors:  H-P Hartung; B Keller-Stanislawski; R A Hughes; H C Lehmann
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

3.  Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.

Authors:  Jürgen Prestel; Peter Volkers; Dirk Mentzer; Helmar C Lehmann; Hans-Peter Hartung; Brigitte Keller-Stanislawski
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-05-10       Impact factor: 2.890

4.  Guillain-Barré syndrome and related diseases after influenza virus infection.

Authors:  Masaki Yamana; Motoi Kuwahara; Yuta Fukumoto; Keisuke Yoshikawa; Kazuo Takada; Susumu Kusunoki
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-05-21

Review 5.  The use of therapeutic plasma exchange as adjunctive therapy in the treatment of coronavirus disease 2019: A critical appraisal of the current evidence.

Authors:  Wen Lu; Walter Kelley; Deanna C Fang; Sarita Joshi; Young Kim; Monika Paroder; Yvette Tanhehco; Minh-Ha Tran; Huy P Pham
Journal:  J Clin Apher       Date:  2021-02-12       Impact factor: 2.605

Review 6.  Neurological events related to influenza A (H1N1) pdm09.

Authors:  Graciela Cárdenas; José Luis Soto-Hernández; Alexandra Díaz-Alba; Yair Ugalde; Jorge Mérida-Puga; Marcos Rosetti; Edda Sciutto
Journal:  Influenza Other Respir Viruses       Date:  2014-05       Impact factor: 4.380
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.